Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
A heart disease study of semaglutide in patients with type 2 diabetes (SOUL, NCT03914326) evaluating the cardiovascular benefit of oral semaglutide is currently underway
Consultado el 4 de febrero de 2026
Dehydration worsens nausea
It's FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition
However, there may be occasions when these medications will be out of a temperature-controlled environment for short periods
[1] [2] Understanding when side effects may emerge is important for both patients and healthcare professionals to ensure appropriate monitoring and management
![Cardiovascular disease continuum-GLP-1 action. Adapted from [46]](https://www.researchgate.net/publication/357072789/figure/fig1/AS:1146405179654167@1650335702879/Cardiovascular-disease-continuum-GLP-1-action-Adapted-from-46.png)
